Table 1 Participants’ characteristics and LDCT scan findings (n = 746)
From: The additional value of lung cancer screening program in identifying unrecognized diseases
Variables | N = 746 |
|---|---|
Age (years) | |
52–58 | 203 (27.2) |
59–64 | 306 (41.0) |
65–78 | 237 (31.8) |
Sex (M) | 462 (61.9) |
Smokers | 540 (72.4) |
Ex-smokers | 206 (27.8) |
Pack year | 49.5 (19.9) |
Professional exposure | 2 (0.27) |
Cancer pathology familiarity | 359 (48.1) |
Comorbidities | |
Asthma | 12 (1.6) |
Diabetes mellitus | 57 (7.6) |
Hypertension | 260 (34.9) |
Gastroesophageal reflux disease | 34 (4.6) |
Hypercholesterolemia | 136 (18.2) |
Hyperthyroidism | 1 (0.1) |
Benign prostatic hyperplasia (BPH) | 47 (6.3) |
Lung nodules | |
Nodules < = 4 mm | 174 (23.3) |
Nodules 5–6 mm | 135 (18.1) |
Nodules 7–8 mm | 43 (5.8) |
Nodules > = 8 mm | 98 (13.1) |
LDCT findings | |
Ground glass opacity | 47 (6.3) |
Centrilobular emphysema | 227 (30.4) |
Paraseptal emphysema | 82 (11) |
Atelectasis areas | 68 (9.1) |
Bronchial wall thickening | 291 (39) |
Bronchiectasis | 62 (8.3) |
Diffuse fibrosis | 14 (1.9) |
Subpleural fibrosis | 277 (37.1) |
Paravertebral fibrosis | 25 (3.4) |
Mucus plugs | 17 (2.3) |
Tracheal deviation | 18 (2.4) |
Focal pleural thickening | 58 (7.8) |
Pleural effusion | 0 (0) |
Vascular Calcifications | 356 (47.7) |
Coronary Calcifications | 276 (37) |
Valve Calcifications | 119 (16) |
Breast nodule | 12 (1.6) |